Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing.

Lee, Chul Seung; Kim, Hoon Seok; Schageman, Jeoffrey; Lee, In Kyu; Kim, Myungshin; Kim, Yonggoo

Lee, Chul Seung; Kim, Hoon Seok; Schageman, Jeoffrey; Lee, In Kyu; Kim, Myungshin; Kim, Yonggoo.

Afiliación

Lee CS; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Kim HS; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Schageman J; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Lee IK; Thermo Fisher Scientific, Austin, TX 78701, USA.
Kim M; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Kim Y; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Cancers (Basel) ; 13(16)2021 Aug 20.

Article en En | MEDLINE | ID: mdl-34439344

Palabras clave

circulating tumor DNA; colorectal cancer; next-generation sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google